Dr. Barry Dworkin

FDA approves new drug to treat pulmonary arterial hypertension

Medical Mythbusting Commentary for March 28, 2024

Source:
FDA approves new drug that may help stop a rare, fatal condition that doctors call a ‘ticking time bomb’

Reference:
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension

Related posts:

  1. New asthma pathway discovery may lead to new approaches to treatment
  2. Scientists find a good treatment target for pulmonary hypertension by uncovering gene responsible for its progression.
  3. Study reviews the drug interactions between cardiac medications and herbal products
  4. BMJ reports birth control pill use not associated with increased long-term risk of death